Health Idea Now
Monday, 18 November 2019
Merck and Bayer's heart drug meets main goal of late-stage study
Merck & Co Inc said on Monday an experimental treatment being developed with Bayer AG for patients with worsening chronic heart failure met the main goal of a late-stage study.
from Reuters: Health News https://ift.tt/37decNY
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment